What should clinicians know about the use of glucocorticoids in systemic sclerosis? - Wikidata - wikimedia - TriplyDB

What should clinicians know about the use of glucocorticoids in systemic sclerosis?

What should clinicians know about the use of glucocorticoids in systemic sclerosis?

http://www.wikidata.org/entity/Q39069685

about

What should clinicians know about the use of glucocorticoids in systemic sclerosis?

http://www.wikidata.org/entity/Q39069685

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

What should clinicians know about the use of glucocorticoids in systemic sclerosis?

@en

What should clinicians know about the use of glucocorticoids in systemic sclerosis?

@nl

type

label

What should clinicians know about the use of glucocorticoids in systemic sclerosis?

@en

What should clinicians know about the use of glucocorticoids in systemic sclerosis?

@nl

prefLabel

What should clinicians know about the use of glucocorticoids in systemic sclerosis?

@en

What should clinicians know about the use of glucocorticoids in systemic sclerosis?

@nl

P1433

Q39069685-9221775F-C5F4-46C3-840C-CBE11FC48DD6

P1476

Q39069685-DEE3AAD0-AC66-40CE-9DF0-41944BD2AF5F

P2093

Q39069685-903E542E-6A64-4B39-945C-82525235FF50

P2860

Q39069685-055C01D8-BD9F-43E8-BD00-3205C317E854

Q39069685-05CADD95-4D10-4C7F-B4E5-DB7174397B33

Q39069685-2006AB18-730C-47FF-B08D-38BB2C81C6B8

Q39069685-28D40E42-8317-462D-96E6-560216E37C26

Q39069685-2CE3A6F4-0858-40FE-9A35-76E4A884932E

Q39069685-30EB464D-60C6-4A26-9E48-6325E2F0D8EB

Q39069685-41860B72-B633-4032-901A-DF75580C9962

Q39069685-47034134-EBFD-4419-B429-8476F356CC1C

Q39069685-4CC5AD93-58F9-46C7-9D18-9B3885B2ED68

Q39069685-50D9BAFB-CD6D-4207-AE04-D4C8D65B74B2

P304

Q39069685-B3E4C8A3-2EEE-4D6A-AC7B-4FF64BE97193

P31

Q39069685-174F953B-9FDE-49FA-8123-647CEA930B1F

P356

Q39069685-9BD2D146-084F-41A3-BAB7-2DCCB2291FC4

P433

Q39069685-C23059EB-D08B-4F41-A86B-C10AB3BF6101

P478

Q39069685-A55822AC-C2C1-4394-8A89-A5559817DE59

P50

Q39069685-CE673838-1658-41F5-9B2F-AAF5C261274B

P577

Q39069685-F25FD987-FDF9-4221-BBC9-AAA4BB672F1C

P698

Q39069685-2166FB85-051A-4057-ADA6-55B8C0E7852D

P356

14397595.2016.1270796

P1433

Modern Rheumatology

P1476

What should clinicians know about the use of glucocorticoids in systemic sclerosis?

@en

P2093

Michele Iudici

http://www.w3.org/2001/XMLSchema#string

P2860

My approach to the treatment of scleroderma

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management

Low-dose oral imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide: a phase II pilot study.

Cyclophosphamide versus placebo in scleroderma lung disease.

A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.

High frequency of corticosteroid and immunosuppressive therapy in patients with systemic sclerosis despite limited evidence for efficacy.

Cyclophosphamide versus mycophenolate mofetil in scleroderma interstitial lung disease (SSc-ILD) as induction therapy: a single-centre, retrospective analysis

Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: a randomized, double-blind, placebo-controlled trial.

EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR).

Prevalence and factors associated with glucocorticoids (GC) use in systemic sclerosis (SSc): a systematic review and meta-analysis of cohort studies and registries.

P304

919-923

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14397595.2016.1270796

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-01-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28058863

http://www.w3.org/2001/XMLSchema#string